Latest in Research & Development

Stabilised transmembrane proteins to accelerate antibody drug discovery

John Cardone, Marketing Manager, Custom Antibodies, at Bio-Rad Laboratories discusses the benefits of combining novel platform technologies to tackle critical bottlenecks in the antibody discovery process

Find out more
You need to be a subscriber to read this article.
Click here to find out more.

You need to be a subscriber to read this article.
Click here to find out more.

Navigating cybersecurity challenges in the medical technology market

Luisa Rusconi, Senior Security Evaluator at SGS, explores how the rising threat of cyberattacks has driven the implementation of stricter regulations and reviews the solutions...
See more

Upperton Pharma Solutions expands with new sterile manufacturing facility

New Nottingham-based site enhances aseptic and terminally sterilised drug production

New centres of excellence for regulation announced to accelerate life-saving innovations

Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients

Servier expands AI partnership with Google Cloud to bolster pharma R&D efforts

The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes

Navin Molecular constructs a new R&D facility in Dewas, India

The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity

Daiichi Sankyo and BioMed X Institute join forces to develop multi-specific biologics for cancer therapy

Through this collaboration, they aim to discover and develop novel target combinations for bi- and multi-specific biologics for the treatment of solid tumours

Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar

FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel

Lonza and Iconovo collaborate to develop intranasal biologic for obesity

The two will aim to create an effective and stable inhaled formulation that can be used to treat obesity without the need for frequent injections

Mythbusting: can the ConsiGma Coater handle friable tablets?

GEA experts investigate the tablet coating process used by the company’s cascade-based ConsiGma® technology to assess its ability to handle less-robust cores

Latest posts in Research & Development

Boehringer Ingelheim ramps up its oncology ADC development with new tech and antigen target

The company has licensed Lonza-owned Synaffix's ADC platform technology, while also claiming the rights to a fourth novel oncology target from an ongoing discovery partnership with Oxford BioTherapeutics

etherna and Dropshot team up to optimise the RNA drug development process in $950m deal

The two companies will combine their LNP and mRNA-based technologies to develop precision medicines for cardiac and renal diseases

Eli Lilly and Alchemab Therapeutics team up to discover and develop ALS antibodies

The agreement could facilitate the commercialisation of up to five new antibody-based therapeutics for amyotrophic lateral sclerosis (ALS)

NMD Pharma's drug candidate for Charcot-Marie-Tooth disease granted ODD by the FDA

The small molecule CIC-1 inhibitor will be used to treat CMT, which currently has no approved treatments

Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research

The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications

BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab

The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance its approved medicine production capacity

Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables

The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively

Bespak and OzUK extend their joint capacity in early-stage pMDI development

The partnership will streamline the pMDI development, testing and pilot scale manufacturing processes to rapidly progress inhaled therapeutics into clinical trials

Concept and Accelero Biostructures accelerate early drug discovery with X-ray crystallography

The companies will incorporate their X-ray crystallography and drug discovery technologies to offer clients rapid hit-to-lead drug development

Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility

The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms

First patient dosed in Phase I trial with a PARP1 selective inhibitor to treat solid tumours

Duke Street Bio is pleased to announce that the first patient has been dosed in a Phase I trial evaluating the highly selective PARP1 inhibitor, DSB2455, in patients with solid tumours

Alanis Therapeutics chooses KBI Biopharma to develop and produce its lead antibody

KBI will be responsible for development, process optimisation and manufacture of the therapeutic monoclonal antibody, which could be used to treat certain haematological malignancies

Sponsor content

How is generative AI driving value in the life sciences sector?

Generative AI has the potential to expedite clinical discovery and to streamline timely processes

Characterising nitrosamine impurities in sartan compounds with an Agilent GC/TQ system with hydrogen carrier gas

Exploring the analysis of nitrosamine contamination in sartan drugs using Agilent's innovative triple quadrupole (TQ) GC/MS system with hydrogen carrier gas

Turning up the heat with Vapourtec’s SF-10+

Enhanced lab pump enables new chemical applications

Tecan unveils Veya to revolutionise lab automation

Scalable platform simplifies workflows, boosts precision, and ensures compliance

Sphere Fluidics launches Cyto-Mine Chroma and announces early access program

A next-generation platform to optimize single-cell analysis workflows for life science R&D
You need to be a subscriber to read this article.
Click here to find out more.

Reducing lead times in toxicology

How automated tools can speed up toxicology tests

CMC Issues are a Leading Cause of Cell & Gene Therapies Clinical Holds

Overcoming CMC challenges to accelerate cell and gene therapy approvals

Almac invests in analytical capabilities with new spectroscopy instrumentation at Craigavon lab

The £500k investment will bring Agilent's 6545XT AdvanceBio Q-TOF Mass Spectrometer and Malvern's Panalytical Empyrean X-Ray Powder Diffractometer to the lab

Piramal Pharma employs renewable energy at its Digiwal API manufacturing facility

Piramal now powers the drug manufacturing site with a steam boiler running off biomass briquettes, contributing to the company's ongoing sustainability efforts

Thermo Fisher Scientific’s Olink platform selected for world’s largest human proteome study

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker discovery

Vacuu·Select: the complete controller for vacuum applications

Intuitive and efficient control for diverse laboratory needs

Precise and efficient VARIO diaphragm pumps from Vacuubrand

Advanced vacuum control for reproducible processes

Featured companies

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech... At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a...
See more